Cimpress raises FY26 revenue growth view to 7%-8%

The company states: “We are raising our previously established FY2026 annual outlook as follows: * Revenue growth of 7% – 8%, and organic constant-currency revenue growth of 3% – 4%. This assumes full-year currency rates similar to recent average rates. Net income of at least $79 million and adjusted EBITDA of at least $460 million. Operating cash flow of $313 million, and adjusted free cash flow of approximately $145 million. FY2026 is a significant year of capital expenditures as we expand our product offering and focused production hubs, which is a key enabler to both organic revenue growth opportunities and lowering our cost structure. As noted previously, our FY2026 guidance incorporates potential trade and macroeconomic risks. We remain well positioned financially to navigate volatility. We remain confident in our ability to deliver our FY2028 targets of at least $200 million in net income and $600 million in adjusted EBITDA, with approximately 45% conversion to adjusted free cash flow. Beyond organic growth, we plan to generate $70 million to $80 million in annualized efficiency benefits exiting FY2027. product expansion and manufacturing and supply chain, have positioned us well to evaluate a healthy pipeline of tuck-in M&A and potential partnership opportunities that we believe in the aggregate can have a positive impact on our results in future years as a part of our roadmap to delivering FY2028 targets. Achieving our FY2028 outlook will generate strong per-share free cash flow growth and significantly reduce our net leverage ratio. We continue to expect net leverage at the end of FY2026 to be slightly below the end of FY2025 level of 3.1x. We expect that we will reduce net leverage to approximately 2.5x trailing-twelve-month EBITDA as calculated under our credit agreement exiting FY2027 on the way to meaningfully below 2.0x net leverage ending this three-year period, subject to capital allocation choices such as share repurchases.”